{"transactions":[{"id":703428,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":57381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57381},"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":703427,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":8319,"price":13.82,"value":114968.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 8,319 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":305796,"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":703426,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":16296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 16,296 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":314115,"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":704636,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:07.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":53257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":53257,"derivative":{"underlying":"Common Stock","underlying_shares":53257},"source":{"system":"sec-edgar","filing":"0001140361-26-029334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029334/form4.xml","form_type":"4"}},{"id":704635,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:07.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":53257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 53,257 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 53,257 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":297819,"source":{"system":"sec-edgar","filing":"0001140361-26-029334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029334/form4.xml","form_type":"4"}},{"id":705130,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":13.71,"value":9830.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":244562,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":705129,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3510,"price":13.51,"value":47420.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":245279,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":705128,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7840,"price":14.14,"value":110857.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":248789,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":1019081,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-10-14T10:11:34.000Z","date":"2025-10-13","kind":"purchase","planned":false,"acquired":true,"shares":890,"price":11.16,"value":9932.4,"ownership":{"direct":true},"balance_after":256629,"source":{"system":"sec-edgar","filing":"0001140361-25-038018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125038018/form4.xml","form_type":"4"}},{"id":1083290,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":667,"price":8.99,"value":5996.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 667 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":255739,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1083289,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":8.69,"value":6230.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":256406,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1083288,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2585,"price":8.69,"value":22463.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,585 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":257123,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1084581,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:23.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":86997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":86997,"derivative":{"underlying":"Common Stock","underlying_shares":86997},"source":{"system":"sec-edgar","filing":"0001140361-25-026462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026462/form4.xml","form_type":"4"}},{"id":1084580,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:23.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":86997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 86,997 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 86,997 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":259708,"source":{"system":"sec-edgar","filing":"0001140361-25-026462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026462/form4.xml","form_type":"4"}},{"id":1389183,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-10-08T22:27:36.000Z","date":"2024-10-08","kind":"purchase","planned":false,"acquired":true,"shares":1700,"price":5.86,"value":9962.0,"ownership":{"direct":true},"balance_after":172711,"source":{"system":"sec-edgar","filing":"0001140361-24-043173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124043173/form4.xml","form_type":"4"}},{"id":1442658,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2024-08-03T01:48:10.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":14817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On July 21, 2021, the reporting person received a target grant of 14,817 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 11,142 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 21, 2021, the reporting person received a target grant of 14,817 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 11,142 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 21, 2021, the reporting person received a target grant of 14,817 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 11,142 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14817},"source":{"system":"sec-edgar","filing":"0001140361-24-035597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035597/form4.xml","form_type":"4"}},{"id":1442657,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-08-03T01:48:10.000Z","date":"2024-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2585,"price":7.18,"value":18560.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 2,585 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares of underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":171011,"source":{"system":"sec-edgar","filing":"0001140361-24-035597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035597/form4.xml","form_type":"4"}},{"id":1442656,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-08-03T01:48:10.000Z","date":"2024-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4016,"price":7.4,"value":29718.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 4,016 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021."}],"balance_after":173596,"source":{"system":"sec-edgar","filing":"0001140361-24-035597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035597/form4.xml","form_type":"4"}},{"id":1442655,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-08-03T01:48:10.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":11142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 11,142 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021."}],"balance_after":177612,"source":{"system":"sec-edgar","filing":"0001140361-24-035597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035597/form4.xml","form_type":"4"}},{"id":1448617,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:16.000Z","date":"2024-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":667,"price":7.13,"value":4755.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 667 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares of underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":166470,"source":{"system":"sec-edgar","filing":"0001140361-24-034268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124034268/form4.xml","form_type":"4"}},{"id":1448616,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:16.000Z","date":"2024-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":7.13,"value":5112.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 717 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":167137,"source":{"system":"sec-edgar","filing":"0001140361-24-034268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124034268/form4.xml","form_type":"4"}},{"id":1451106,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-19T21:18:27.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":76458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 17, 2025, such that 25% of the options will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":76458,"derivative":{"exercise_price":7.4,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":76458},"source":{"system":"sec-edgar","filing":"0001140361-24-033629","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033629/form4.xml","form_type":"4"}},{"id":1451105,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2024-07-19T21:18:27.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":77905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":77905,"derivative":{"underlying":"Common Stock","underlying_shares":77905},"source":{"system":"sec-edgar","filing":"0001140361-24-033629","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033629/form4.xml","form_type":"4"}},{"id":1451104,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-07-19T21:18:27.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":38953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 38,953 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 38,953 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 17, 2025, such that 25% of the restricted stock units will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":167854,"source":{"system":"sec-edgar","filing":"0001140361-24-033629","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033629/form4.xml","form_type":"4"}},{"id":1602600,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-03-05T01:49:30.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":1927,"price":4.67,"value":8999.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":128901,"source":{"system":"sec-edgar","filing":"0001140361-24-011190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124011190/form4.xml","form_type":"4"}},{"id":1775308,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2023-09-22T01:28:56.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":30242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 19,354 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 19,354 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 19,354 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30242},"source":{"system":"sec-edgar","filing":"0001140361-23-044840","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044840/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775307,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-09-22T01:28:56.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":6975,"price":8.92,"value":62217.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 6,975 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":126974,"source":{"system":"sec-edgar","filing":"0001140361-23-044840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044840/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775306,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-09-22T01:28:56.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":19354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 19,354 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":133949,"source":{"system":"sec-edgar","filing":"0001140361-23-044840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044840/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1822737,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2023-07-27T01:32:26.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":30242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30242},"source":{"system":"sec-edgar","filing":"0001140361-23-036318","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036318/form4.xml","form_type":"4"}},{"id":1822736,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:26.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3159,"price":8.92,"value":28178.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,159 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":120205,"source":{"system":"sec-edgar","filing":"0001140361-23-036318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036318/form4.xml","form_type":"4"}},{"id":1822735,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:26.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":8769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 8,769 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":123364,"source":{"system":"sec-edgar","filing":"0001140361-23-036318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036318/form4.xml","form_type":"4"}},{"id":1823430,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-25T23:07:06.000Z","date":"2023-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":667,"price":8.65,"value":5769.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 667 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":114595,"source":{"system":"sec-edgar","filing":"0001140361-23-036121","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036121/form4.xml","form_type":"4"}},{"id":1823429,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-25T23:07:06.000Z","date":"2023-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":8.74,"value":6266.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 717 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":115262,"source":{"system":"sec-edgar","filing":"0001140361-23-036121","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036121/form4.xml","form_type":"4"}},{"id":1824714,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-22T01:11:21.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":59378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":59378,"derivative":{"exercise_price":8.92,"exercise_date":"2024-07-19","expiration_date":"2033-07-19","underlying":"Common Stock","underlying_shares":59378},"source":{"system":"sec-edgar","filing":"0001140361-23-035726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035726/form4.xml","form_type":"4"}},{"id":1824713,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2023-07-22T01:11:21.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":57381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":57381,"derivative":{"underlying":"Common Stock","underlying_shares":57381},"source":{"system":"sec-edgar","filing":"0001140361-23-035726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035726/form4.xml","form_type":"4"}},{"id":1824712,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-22T01:11:21.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":28691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 28,691 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 28,691 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":115979,"source":{"system":"sec-edgar","filing":"0001140361-23-035726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035726/form4.xml","form_type":"4"}},{"id":1827692,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:37.000Z","date":"2023-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":376,"price":9.56,"value":3594.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 376 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":87288,"source":{"system":"sec-edgar","filing":"0001140361-23-035087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035087/form4.xml","form_type":"4"}},{"id":1827691,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:37.000Z","date":"2023-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1362,"price":9.63,"value":13116.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,362 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":87664,"source":{"system":"sec-edgar","filing":"0001140361-23-035087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035087/form4.xml","form_type":"4"}},{"id":2028168,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-02-07T21:02:52.000Z","date":"2023-02-03","kind":"tax_withholding","acquired":false,"shares":555,"price":13.43,"value":7453.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 555 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 3, 2020."}],"balance_after":89026,"source":{"system":"sec-edgar","filing":"0001567619-23-002005","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761923002005/doc1.xml","form_type":"4"}},{"id":2138167,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-10-12T21:23:09.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":1083,"price":13.82,"value":14967.06,"ownership":{"direct":true},"balance_after":89581,"source":{"system":"sec-edgar","filing":"0001567619-22-018449","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922018449/doc1.xml","form_type":"4"}},{"id":2203172,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-07-22T22:30:44.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":18650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":18650,"derivative":{"exercise_price":21.53,"exercise_date":"2023-07-20","expiration_date":"2032-07-20","underlying":"Common Stock","underlying_shares":18650},"source":{"system":"sec-edgar","filing":"0001567619-22-014367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014367/doc1.xml","form_type":"4"}},{"id":2203171,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2022-07-22T22:30:44.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":15922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":15922,"derivative":{"underlying":"Common Stock","underlying_shares":15922},"source":{"system":"sec-edgar","filing":"0001567619-22-014367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014367/doc1.xml","form_type":"4"}},{"id":2203170,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-07-22T22:30:44.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":7961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 7,961 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 7,961 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":88498,"source":{"system":"sec-edgar","filing":"0001567619-22-014367","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014367/doc1.xml","form_type":"4"}},{"id":2206204,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2022-07-18T20:13:11.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":14758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options for one-fourth of the shares were each exercisable beginning 7/22/2016, 7/22/2017, 7/22/2018 and 7/22/2019, respectively."}],"balance_after":0,"derivative":{"exercise_price":15.95,"exercise_date":"2016-07-22","expiration_date":"2022-07-22","underlying":"Common Stock","underlying_shares":14758},"source":{"system":"sec-edgar","filing":"0001567619-22-014114","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014114/doc1.xml","form_type":"4"}},{"id":2206203,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-07-18T20:13:11.000Z","date":"2022-07-15","kind":"tax_withholding","acquired":false,"shares":12398,"price":21.32,"value":264325.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 12,398 shares of common stock of AngioDynamics, Inc. (the \"Company\") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022."}],"balance_after":80537,"source":{"system":"sec-edgar","filing":"0001567619-22-014114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014114/doc1.xml","form_type":"4"}},{"id":2206202,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-07-18T20:13:11.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":14758,"price":15.95,"value":235390.1,"ownership":{"direct":true},"balance_after":92935,"source":{"system":"sec-edgar","filing":"0001567619-22-014114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014114/doc1.xml","form_type":"4"}},{"id":2209127,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2022-07-11T10:12:52.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 4,188 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 4,188 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 4,188 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001567619-22-013844","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013844/doc1.xml","form_type":"4"}},{"id":2209126,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-07-11T10:12:52.000Z","date":"2022-07-07","kind":"tax_withholding","acquired":false,"shares":1509,"price":20.54,"value":30994.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,509 shares of Common Stock to the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":78177,"source":{"system":"sec-edgar","filing":"0001567619-22-013844","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013844/doc1.xml","form_type":"4"}},{"id":2209125,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-07-11T10:12:52.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":4188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 4,188 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019."}],"balance_after":79686,"source":{"system":"sec-edgar","filing":"0001567619-22-013844","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013844/doc1.xml","form_type":"4"}},{"id":2411475,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-02-04T21:38:56.000Z","date":"2022-02-03","kind":"tax_withholding","acquired":false,"shares":583,"price":20.48,"value":11939.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 583 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 3, 2020."}],"balance_after":75498,"source":{"system":"sec-edgar","filing":"0001567619-22-002518","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922002518/doc1.xml","form_type":"4"}},{"id":2436571,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2022-01-12T21:44:55.000Z","date":"2022-01-12","kind":"purchase","acquired":true,"shares":1000,"price":22.64,"value":22640.0,"ownership":{"direct":true},"balance_after":76081,"source":{"system":"sec-edgar","filing":"0001567619-22-001116","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922001116/doc1.xml","form_type":"4"}},{"id":2456045,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-30T22:54:57.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":20128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of stock options of AngioDynamics, Inc., which contained an administrative error as to the exercise price of such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The exempt disposition of 354 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":20128,"derivative":{"exercise_price":26.49,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":20128},"source":{"system":"sec-edgar","filing":"0001567619-21-022707","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921022707/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2597492,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2021-08-18T11:02:18.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":9437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 9,437 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 10,946 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 9,437 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 10,946 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 9,437 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 10,946 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9437},"source":{"system":"sec-edgar","filing":"0001567619-21-016021","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016021/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597491,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-08-18T11:02:18.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":4173,"price":27.29,"value":113881.17,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 4,173 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018."}],"balance_after":75081,"source":{"system":"sec-edgar","filing":"0001567619-21-016021","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016021/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597490,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-08-18T11:02:18.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":10946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F2","text":"This acquisition of 10,946 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018."}],"balance_after":79254,"source":{"system":"sec-edgar","filing":"0001567619-21-016021","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016021/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2599652,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2021-08-17T10:23:36.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 8,357 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001567619-21-015946","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015946/doc1.xml","form_type":"4"}},{"id":2599651,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-08-17T10:23:36.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":1231,"price":27.29,"value":33593.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,231 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":70308,"source":{"system":"sec-edgar","filing":"0001567619-21-015946","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015946/doc1.xml","form_type":"4"}},{"id":2599650,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-08-17T10:23:36.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":3231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,231 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019."}],"balance_after":71539,"source":{"system":"sec-edgar","filing":"0001567619-21-015946","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015946/doc1.xml","form_type":"4"}},{"id":2623685,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-07-27T23:01:20.000Z","date":"2021-07-26","kind":"tax_withholding","acquired":false,"shares":353,"price":26.1,"value":9213.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 353 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":68308,"source":{"system":"sec-edgar","filing":"0001567619-21-014062","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921014062/doc1.xml","form_type":"4"}},{"id":2625770,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":20128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":20128,"derivative":{"exercise_price":10.27,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":20128},"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2625769,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":14817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":14817,"derivative":{"underlying":"Common Stock","underlying_shares":14817},"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2625768,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":7408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The acquisition of 7,408 shares of Common Stock of the Company represents 7,408 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":68661,"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2625767,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-18","kind":"tax_withholding","acquired":false,"shares":400,"price":24.76,"value":9904.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 400 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":61253,"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2625766,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-17","kind":"tax_withholding","acquired":false,"shares":354,"price":24.76,"value":8765.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 354 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":61653,"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2625765,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-07-23T22:53:00.000Z","date":"2021-07-14","kind":"tax_withholding","acquired":false,"shares":1284,"price":26.43,"value":33936.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,284 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":62007,"source":{"system":"sec-edgar","filing":"0001567619-21-013929","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013929/doc1.xml","form_type":"4"}},{"id":2746754,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-16T21:39:13.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":13625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options for one-fourth of the shares became exercisable on 7/25/2015, 7/25/2016, 7/25/2017 and 7/25/2018, respectively."}],"balance_after":0,"derivative":{"exercise_price":14.07,"exercise_date":"2018-07-25","expiration_date":"2021-07-25","underlying":"Common Stock","underlying_shares":13625},"source":{"system":"sec-edgar","filing":"0001567619-21-008240","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921008240/doc1.xml","form_type":"4"}},{"id":2746753,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-04-16T21:39:13.000Z","date":"2021-04-15","kind":"tax_withholding","acquired":false,"shares":10080,"price":24.21,"value":244036.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The disposition of 10,080 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. reflects a net exercise of options expiring on July 25, 2021, in which shares of Common Stock were disposed to satisfy the payment of the exercise price and tax withholding obligations."}],"balance_after":63291,"source":{"system":"sec-edgar","filing":"0001567619-21-008240","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921008240/doc1.xml","form_type":"4"}},{"id":2746752,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-04-16T21:39:13.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":13625,"price":14.07,"value":191703.75,"ownership":{"direct":true},"balance_after":73371,"source":{"system":"sec-edgar","filing":"0001567619-21-008240","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921008240/doc1.xml","form_type":"4"}},{"id":2878936,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2021-02-04T21:27:55.000Z","date":"2021-02-03","kind":"tax_withholding","acquired":false,"shares":527,"price":19.24,"value":10139.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 527 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 3, 2020."}],"balance_after":59746,"source":{"system":"sec-edgar","filing":"0001567619-21-002187","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921002187/doc1.xml","form_type":"4"}},{"id":3059941,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-08-12T20:14:05.000Z","date":"2020-08-11","kind":"purchase","acquired":true,"shares":1013,"price":9.38,"value":9501.94,"ownership":{"direct":true},"balance_after":60273,"source":{"system":"sec-edgar","filing":"0001567619-20-014905","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920014905/doc1.xml","form_type":"4"}},{"id":3074728,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-28T20:43:05.000Z","date":"2020-07-27","kind":"tax_withholding","acquired":false,"shares":292,"price":8.8,"value":2569.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 292 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":59260,"source":{"system":"sec-edgar","filing":"0001567619-20-013828","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013828/doc1.xml","form_type":"4"}},{"id":3074727,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-28T20:43:05.000Z","date":"2020-07-26","kind":"tax_withholding","acquired":false,"shares":314,"price":8.8,"value":2763.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 314 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":59552,"source":{"system":"sec-edgar","filing":"0001567619-20-013828","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013828/doc1.xml","form_type":"4"}},{"id":3078619,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-21T23:36:04.000Z","date":"2020-07-18","kind":"tax_withholding","acquired":false,"shares":152,"price":9.21,"value":1399.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 152 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":59866,"source":{"system":"sec-edgar","filing":"0001567619-20-013548","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013548/doc1.xml","form_type":"4"}},{"id":3078618,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-21T23:36:04.000Z","date":"2020-07-18","kind":"tax_withholding","acquired":false,"shares":248,"price":9.21,"value":2284.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 248 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":60018,"source":{"system":"sec-edgar","filing":"0001567619-20-013548","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013548/doc1.xml","form_type":"4"}},{"id":3078617,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-21T23:36:04.000Z","date":"2020-07-17","kind":"tax_withholding","acquired":false,"shares":354,"price":9.46,"value":3348.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 354 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":60266,"source":{"system":"sec-edgar","filing":"0001567619-20-013548","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013548/doc1.xml","form_type":"4"}},{"id":3080204,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-18T01:44:53.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":44510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 14, 2021, such that 25% of the options will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":44510,"derivative":{"exercise_price":9.92,"exercise_date":"2021-07-14","expiration_date":"2030-07-14","underlying":"Common Stock","underlying_shares":44510},"source":{"system":"sec-edgar","filing":"0001567619-20-013440","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013440/doc1.xml","form_type":"4"}},{"id":3080203,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2020-07-18T01:44:53.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":30242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":30242,"derivative":{"underlying":"Common Stock","underlying_shares":30242},"source":{"system":"sec-edgar","filing":"0001567619-20-013440","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013440/doc1.xml","form_type":"4"}},{"id":3080202,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-18T01:44:53.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":15121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 15,121 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 15,121 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 14, 2021, such that 25% of the restricted stock units will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":60620,"source":{"system":"sec-edgar","filing":"0001567619-20-013440","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013440/doc1.xml","form_type":"4"}},{"id":3284221,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-02-07T13:27:27.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":18204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on February 3, 2021, such that 25% of the options will vest on each of February 3, 2021, 2022, 2023 and 2024."}],"balance_after":18204,"derivative":{"exercise_price":13.8,"exercise_date":"2021-02-03","expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":18204},"source":{"system":"sec-edgar","filing":"0001567619-20-002340","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920002340/doc1.xml","form_type":"4"}},{"id":3284220,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel and CFO"}}],"security":"Common Stock","published_at":"2020-02-07T13:27:27.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":5376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 5,376 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 5,376 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on February 3, 2021, such that 25% of the restricted stock units will vest on each of February 3, 2021, 2022, 2023 and 2024."}],"balance_after":45499,"source":{"system":"sec-edgar","filing":"0001567619-20-002340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920002340/doc1.xml","form_type":"4"}},{"id":3390952,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Performance Right","published_at":"2019-10-18T22:35:37.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":8357,"derivative":{"underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001567619-19-019778","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919019778/doc1.xml","form_type":"4"}},{"id":3432925,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Performance Right","published_at":"2019-08-20T10:14:54.000Z","date":"2019-07-12","kind":"exercise","acquired":false,"shares":6894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,894 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,585 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,894 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,585 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,894 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,585 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6894},"source":{"system":"sec-edgar","filing":"0001567619-19-017322","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017322/doc1.xml","form_type":"4"}},{"id":3432924,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-08-20T10:14:54.000Z","date":"2019-07-12","kind":"tax_withholding","acquired":false,"shares":1185,"price":21.68,"value":25690.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,185 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 27, 2016."}],"balance_after":40123,"source":{"system":"sec-edgar","filing":"0001567619-19-017322","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017322/doc1.xml","form_type":"4"}},{"id":3432923,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-08-20T10:14:54.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":3585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,585 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 27, 2016."}],"balance_after":41308,"source":{"system":"sec-edgar","filing":"0001567619-19-017322","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017322/doc1.xml","form_type":"4"}},{"id":3448866,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-08-02T20:26:15.000Z","date":"2019-07-27","kind":"tax_withholding","acquired":false,"shares":285,"price":20.91,"value":5959.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 285 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":37723,"source":{"system":"sec-edgar","filing":"0001567619-19-015718","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015718/doc1.xml","form_type":"4"}},{"id":3448865,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-08-02T20:26:15.000Z","date":"2019-07-26","kind":"tax_withholding","acquired":false,"shares":306,"price":20.89,"value":6392.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 306 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":38008,"source":{"system":"sec-edgar","filing":"0001567619-19-015718","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015718/doc1.xml","form_type":"4"}},{"id":3448864,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-08-02T20:26:15.000Z","date":"2019-07-22","kind":"tax_withholding","acquired":false,"shares":355,"price":21.38,"value":7589.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 355 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015."}],"balance_after":38314,"source":{"system":"sec-edgar","filing":"0001567619-19-015718","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015718/doc1.xml","form_type":"4"}},{"id":3455855,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-07-25T20:51:24.000Z","date":"2019-07-22","kind":"tax_withholding","acquired":false,"shares":355,"price":21.38,"value":7589.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 355 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015."}],"balance_after":38669,"source":{"system":"sec-edgar","filing":"0001567619-19-015205","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015205/doc1.xml","form_type":"4"}},{"id":3455854,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-07-25T20:51:24.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":148,"price":21.53,"value":3186.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 148 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":39024,"source":{"system":"sec-edgar","filing":"0001567619-19-015205","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015205/doc1.xml","form_type":"4"}},{"id":3455853,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-07-25T20:51:24.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":241,"price":21.53,"value":5188.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 241 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":39172,"source":{"system":"sec-edgar","filing":"0001567619-19-015205","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015205/doc1.xml","form_type":"4"}},{"id":3458420,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-20T01:32:22.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":13975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":13975,"derivative":{"exercise_price":21.54,"exercise_date":"2020-07-17","expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":13975},"source":{"system":"sec-edgar","filing":"0001567619-19-015044","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015044/doc1.xml","form_type":"4"}},{"id":3458419,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-07-20T01:32:22.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":4178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 4,178 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 4,178 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":39413,"source":{"system":"sec-edgar","filing":"0001567619-19-015044","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015044/doc1.xml","form_type":"4"}},{"id":3548595,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-04-26T00:21:45.000Z","date":"2019-04-24","kind":"tax_withholding","acquired":false,"shares":1319,"price":20.64,"value":27224.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,319 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 24, 2015."}],"balance_after":35235,"source":{"system":"sec-edgar","filing":"0001567619-19-009204","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919009204/doc1.xml","form_type":"4"}},{"id":3835714,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Performance Right","published_at":"2018-08-22T23:05:45.000Z","date":"2018-07-12","kind":"exercise","acquired":false,"shares":5737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 22, 2015, the reporting person received a target grant of 5,737 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2016, 2017 and 2018.  Based on the Company's performance over this period, 3,556 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 22, 2015, the reporting person received a target grant of 5,737 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2016, 2017 and 2018.  Based on the Company's performance over this period, 3,556 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 22, 2015, the reporting person received a target grant of 5,737 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2016, 2017 and 2018.  Based on the Company's performance over this period, 3,556 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5737},"source":{"system":"sec-edgar","filing":"0001567619-18-001675","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761918001675/doc1.xml","form_type":"4"}},{"id":3835713,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-08-22T23:05:45.000Z","date":"2018-07-12","kind":"tax_withholding","acquired":false,"shares":1175,"price":20.5,"value":24087.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,175 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 22, 2015."}],"balance_after":38935,"source":{"system":"sec-edgar","filing":"0001567619-18-001675","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761918001675/doc1.xml","form_type":"4"}},{"id":3835712,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-08-22T23:05:45.000Z","date":"2018-07-12","kind":"exercise","acquired":true,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,556 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 22, 2015."}],"balance_after":40110,"source":{"system":"sec-edgar","filing":"0001567619-18-001675","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761918001675/doc1.xml","form_type":"4"}},{"id":3858920,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-07-30T22:57:41.000Z","date":"2018-07-27","kind":"tax_withholding","acquired":false,"shares":285,"price":21.42,"value":6104.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 285 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":36554,"source":{"system":"sec-edgar","filing":"0001140361-18-034277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118034277/doc1.xml","form_type":"4"}},{"id":3859852,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-07-28T00:13:22.000Z","date":"2018-07-26","kind":"tax_withholding","acquired":false,"shares":306,"price":21.88,"value":6695.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 306 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":36839,"source":{"system":"sec-edgar","filing":"0001140361-18-033950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033950/doc1.xml","form_type":"4"}},{"id":3859851,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-07-28T00:13:22.000Z","date":"2018-07-25","kind":"tax_withholding","acquired":false,"shares":391,"price":21.5,"value":8406.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 391 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 25, 2014."}],"balance_after":37145,"source":{"system":"sec-edgar","filing":"0001140361-18-033950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033950/doc1.xml","form_type":"4"}},{"id":3859850,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-07-28T00:13:22.000Z","date":"2018-07-22","kind":"tax_withholding","acquired":false,"shares":355,"price":21.67,"value":7692.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 355 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015."}],"balance_after":37536,"source":{"system":"sec-edgar","filing":"0001140361-18-033950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033950/doc1.xml","form_type":"4"}}],"next_cursor":"2018-07-28T00:13:22.000000Z,3859850"}